BMS Newsroom |

5/16/13 4:30 pm EDT
Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock
5/15/13 6:10 pm EDT
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
5/15/13 6:00 pm EDT
Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting
5/14/13 3:18 pm EDT
Bristol-Myers Squibb to Present at UBS Global Health Care Conference
5/8/13 10:30 am EDT
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
5/6/13 5:00 pm EDT
Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
5/6/13 7:00 am EDT
Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period
5/3/13 8:00 am EDT
Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients
4/25/13 7:30 am EDT
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
4/23/13 8:00 am EDT
Former Pro Football Coach Bill Cowher Tells Men “No Excuses” When It Comes to Getting Screened for Melanoma

Business Wire NewsHQ℠